[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340991-105":59,"doc-detail-340991-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-relationship-between-thyroid-peroxidase-antibody-and-differentiated-thyroid-cancer-a-systematic-review-and-meta-analysis","The relationship between thyroid peroxidase antibody and differentiated thyroid cancer - a systematic review and meta-analysis","","Thyroid peroxidase antibody (TPOAb) has been proposed as a marker linked to differentiated thyroid cancer (DTC), yet evidence remains inconsistent. This systematic review and meta-analysis searched PubMed, Embase, Cochrane Library, and Web of Science up to July 2023. Twelve studies with 20,330 participants were analyzed, comparing TPOAb-positive versus TPOAb-negative groups and assessing incidence, tumor characteristics, and clinical outcomes. Results showed higher DTC risk and greater bilateral and multifocal tumor presentation among TPOAb-positive individuals, while key prognostic endpoints showed no significant differences.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-relationship-between-thyroid-peroxidase-antibody-and-differentiated-thyroid-cancer-a-systematic-review-and-meta-analysis/340991/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-relationship-between-thyroid-peroxidase-antibody-and-differentiated-thyroid-cancer-a-systematic-review-and-meta-analysis/340991.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this systematic review address about TPOAb and DTC?","Question",{"text":112,"@type":113},"It examines whether thyroid peroxidase antibody (TPOAb) is associated with differentiated thyroid cancer (DTC), focusing on incidence and multiple tumor and clinical outcome measures.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many studies and participants were included in the meta-analysis?",{"text":117,"@type":113},"Twelve original studies were included, totaling 20,330 subjects.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes were significantly different for TPOAb-positive versus TPOAb-negative individuals?",{"text":121,"@type":113},"TPOAb-positive individuals showed a higher risk of developing DTC and were more likely to present with bilateral and multifocal tumors. However, extrathyroidal extension, lymph node metastasis, recurrence, and tumor size did not differ significantly.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340991,1790868104,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","TYPE Systematic Review PUBLISHED 27 February 2024 DOI 10.3389/fendo.2024.1349041  \nOPEN ACCESS  \nEDITED BY  \nVincenzo Marotta,  \nAOU S. Giovanni di Dio e Ruggi D’Aragona, Italy  \nREVIEWED BY  \nElisa Minaldi, University of Pisa, Italy Marlena Godlewska,  \nCentrum Medyczne Kształcenia Podyplomowego, Poland  \n*CORRESPONDENCE Xiaoguang Shi  \n [xiaoguangshi_cmu@163.com](xiaoguangshi_cmu@163.com)  \nRECEIVED 04 December 2023  \nACCEPTED 13 February 2024  \nPUBLISHED 27 February 2024  \nCITATION  \nZhang H, Tian L, Wang X and Shi X (2024) The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.  \nFront. Endocrinol. 15:1349041 .  \ndoi: 10.3389/fendo.2024.1349041  \nCOPYRIGHT  \n© 2024 Zhang, Tian, Wang and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis  \nHaonan Zhang 1, Lijun Tian 2, Xichang Wang 1 and Xiaoguang Shi 1*  \n1 Department of Endocrinology and Metabolism, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China, 2 Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning, China  \nBackground: Thyroglobulin antibody (TgAb) has been found to be associated with the occurrence and development of differentiated thyroid cancer (DTC) for several years, but there is still controversy over whether thyroid peroxidase antibody (TPOAb) is related to differentiated thyroid cancer.  \nMethods: We scrutinized relevant studies published up to July 2023 across four major databases including PubMed, Embase, Cochrane Library, and Web of Science, to examine the association between TPOAb and DTC. Clinical outcome measures include the incidence of DTC, tumor size, extrathyroidal invasion, lymph node metastasis, multifocality, recurrence and bilaterality.  \nResults: 12 original studies were included, involving a total of 20,330 subjects. Our analysis of the included studies revealed that TPOAb+ individuals exhibited a higher risk of developing DTC (OR=1.57 [95% CI: 1.00–2.45], p=0.049) than TPOAb– individuals. Furthermore, TPOAb+ DTC patients were more prone to present with bilateral (OR=1.40 [95% CI: 1.21–1.62], p\u003C0.00001) and multifocal (OR=1 . 40 [95% CI: 1 .23-1. 60], p\u003C0 . 00001) tumors than TPOAb– patients. Sensitivity analysis indicated a high sensitivity for these three ﬁndings. No signiﬁcant differences in the risk of extrathyroidal extension and lymph node metastasis, recurrence rate, tumor size, were observed between TPOAb+ and TPOAb– DTC patients.  \nConclusion: The presence of TPOAb is correlated with an increase prevalence of DTC. However, its effectiveness as a prognostic marker for DTC patients warrants further investigation.  \nSystematic review registration: [https://www.crd.york.ac. uk/PROSPERO/](https://www.crd.york.ac. uk/PROSPERO/) , identiﬁer CRD42023448824 .  \nKEYWORDS  \ndifferentiated thyroid cancer, thyroid peroxidase antibody, prevalence, prognosis, meta analysis  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nThyroid cancer is one of the most prevalent endocrine malignancies, with its annual incidence increasing in numerous countries and regions. However, the mortality rate remains consistently low (1, 2) . Differentiated thyroid cancer (DTC) is the most frequently diagnosed type, accounting for over 95% of cases (3) . DTC comprises two main subtypes, with papillary thyroid cancer (PTC) account","cbCaimzBYHdW0MRj","https://ap.wps.com/l/cbCaimzBYHdW0MRj","pdf",1873572,"English","# Introduction\n# Background\n# Methods\n# Results\n# Conclusion\n# Systematic Review Registration\n# Keywords","[{\"question\":\"What question does this systematic review address about TPOAb and DTC?\",\"answer\":\"It examines whether thyroid peroxidase antibody (TPOAb) is associated with differentiated thyroid cancer (DTC), focusing on incidence and multiple tumor and clinical outcome measures.\"},{\"question\":\"How many studies and participants were included in the meta-analysis?\",\"answer\":\"Twelve original studies were included, totaling 20,330 subjects.\"},{\"question\":\"What outcomes were significantly different for TPOAb-positive versus TPOAb-negative individuals?\",\"answer\":\"TPOAb-positive individuals showed a higher risk of developing DTC and were more likely to present with bilateral and multifocal tumors. However, extrathyroidal extension, lymph node metastasis, recurrence, and tumor size did not differ significantly.\"}]","The relationship between thyroid peroxidase antibody and differentiated thyroid cancer - a systematic review and meta-analysis | PDF",1790039844,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/403c5af1a44ef6bc47876c7dc4a79c73.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2be492728ebae573a8c87ae5ea8ef60f.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee1e0a2a18019e3cfdf2209bba6285dd.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57b31fd71d700b6470cbaaf4b9fc6367.webp",980,692]